Top Legislation - View All
Latest Action: 03/07/2007 - Assigned to Subcommittee Civil Practice and Procedure of JUD Bill TextCompanion Bill SB2038. Controlled Substances - Adds Soma (Carisoprodol) and Ultram (Tramadol) to Schedule IV controlled substances; requires person to show identification and sign a log at time of purchase of any controlled substance. - Amends TCA Title 39, Chapter 17, Part 4 and Title 63, Chapter 10. Fiscal Summary for *HB1853 / SB2038Increase State Expenditures - Not Significant Increase State Revenues - Not Significant Bill Summary for *HB1853 / SB2038 This bill adds the drugs Soma (Carisoprodol) and Ultram (Tramadol) to the list of Schedule IV controlled substances. This bill also requires pharmacists and pharmacy technicians and interns under the pharmacist's supervision to require any person purchasing any scheduled controlled substance to present a valid government-issued identification at the point of sale and sign a log. A [...] show full description
Latest Action: 06/27/2007 - Public Chapter 498 Bill TextCompanion Bill SB2172. Controlled Substances - Revises provisions governing the disclosure of information obtained under the Controlled Substance Monitoring Act; requires annual report to be filed with certain general assembly committees. - Amends TCA Sections 53-10-306. Fiscal Summary for *HB2234 / SB2172Decrease State Expenditures - Not Significant Bill Summary for *HB2234 / SB2172 Present law requires any health care practitioner who has authority to dispense controlled substances, pharmacists, and pharmacies that dispense to any address within this state to submit information to the controlled substance database advisory committee regarding each dispensation of any Schedule II, III, or IV, and Schedule V controlled substances identified by the committee as demonstrating a potential for abuse. The information required in the reports includes [...] show full description
Latest Action: 06/27/2007 - Companion became Public Chapter 518 Bill TextCompanion Bill SB2192. Controlled Substances - Transfers responsibilities with respect to controlled substance monitoring, including the database and advisory committee, from the department of commerce and insurance to the department of health. - Amends TCA Title 53, Chapter 10, Part 3. Fiscal Summary for *HB2249 / SB2192Increase State Expenditures - Not Significant Bill Summary for *HB2249 / SB2192 ON JUNE 6, 2007, THE SENATE ADOPTED AMENDMENTS #1 AND #2 AND PASSED SENATE BILL 2192, AS AMENDED. AMENDMENT #1 rewrites this bill to transfer the responsibilities with respect to controlled substance monitoring, including the controlled substance database and the controlled substance database advisory committee, from the department and the commissioner of commerce and insurance to the department and commissioner of health. This amendment [...] show full description
Latest Action: 06/06/2007 - Companion became Public Chapter 298 Bill TextCompanion Bill SB2216. Controlled Substances - Adds certain drugs to controlled substances schedule, thereby making it an offense to manufacture, deliver, sell, or possess with the intent to manufacture, deliver, or sell the drug. - Amends TCA Title 39, Chapter 17, Part 4. Fiscal Summary for *HB2267 / SB2216(CORRECTED) Increase State Expenditures - $2,200 / Incarceration* Increase Local Govt. Expenditures - Not Significant Increase Local Govt. Revenues - Not Significant Bill Summary for *HB2267 / SB2216 This bill adds numerous opiates, depressants, stimulants, and narcotics to Schedules I through V of the controlled substances schedule, thereby making it a criminal offense to manufacture, deliver, sell, or possess with the intent to manufacture, deliver, or sell the drugs. This bill moves the depressant glutethimide from Schedule [...] show full description
Latest Action: 04/17/2007 - Assigned to Gen. Sub of: Senate Jud Comm. Bill TextCompanion Bill HB1853. Controlled Substances - Adds Soma (Carisoprodol) and Ultram (Tramadol) to Schedule IV controlled substances; requires person to show identification and sign a log at time of purchase of any controlled substance. - Amends TCA Title 39, Chapter 17, Part 4 and Title 63, Chapter 10. Fiscal Summary for SB2038 / *HB1853Increase State Expenditures - Not Significant Increase State Revenues - Not Significant Bill Summary for SB2038 / *HB1853 This bill adds the drugs Soma (Carisoprodol) and Ultram (Tramadol) to the list of Schedule IV controlled substances. This bill also requires pharmacists and pharmacy technicians and interns under the pharmacist's supervision to require any person purchasing any scheduled controlled substance to present a valid government-issued identification at the point of sale and sign a log. A [...] show full description
Latest Action: 06/27/2007 - Companion became Public Chapter 498 Bill TextCompanion Bill HB2234. Controlled Substances - Revises provisions governing the disclosure of information obtained under the Controlled Substance Monitoring Act; requires annual report to be filed with certain general assembly committees. - Amends TCA Sections 53-10-306. Fiscal Summary for SB2172 / *HB2234Decrease State Expenditures - Not Significant Bill Summary for SB2172 / *HB2234 Present law requires any health care practitioner who has authority to dispense controlled substances, pharmacists, and pharmacies that dispense to any address within this state to submit information to the controlled substance database advisory committee regarding each dispensation of any Schedule II, III, or IV, and Schedule V controlled substances identified by the committee as demonstrating a potential for abuse. The information required in the reports includes [...] show full description
Latest Action: 06/27/2007 - Public Chapter 518 Bill TextCompanion Bill HB2249. Controlled Substances - Transfers responsibilities with respect to controlled substance monitoring, including the database and advisory committee, from the department of commerce and insurance to the department of health. - Amends TCA Title 53, Chapter 10, Part 3. Fiscal Summary for SB2192 / *HB2249Increase State Expenditures - Not Significant Bill Summary for SB2192 / *HB2249 ON JUNE 6, 2007, THE SENATE ADOPTED AMENDMENTS #1 AND #2 AND PASSED SENATE BILL 2192, AS AMENDED. AMENDMENT #1 rewrites this bill to transfer the responsibilities with respect to controlled substance monitoring, including the controlled substance database and the controlled substance database advisory committee, from the department and the commissioner of commerce and insurance to the department and commissioner of health. This amendment [...] show full description
Latest Action: 06/06/2007 - Public Chapter 298 Bill TextCompanion Bill HB2267. Controlled Substances - Adds certain drugs to controlled substances schedule, thereby making it an offense to manufacture, deliver, sell, or possess with the intent to manufacture, deliver, or sell the drug. - Amends TCA Title 39, Chapter 17, Part 4. Fiscal Summary for SB2216 / *HB2267(CORRECTED) Increase State Expenditures - $2,200 / Incarceration* Increase Local Govt. Expenditures - Not Significant Increase Local Govt. Revenues - Not Significant Bill Summary for SB2216 / *HB2267 This bill adds numerous opiates, depressants, stimulants, and narcotics to Schedules I through V of the controlled substances schedule, thereby making it a criminal offense to manufacture, deliver, sell, or possess with the intent to manufacture, deliver, or sell the drugs. This bill moves the depressant glutethimide from Schedule [...] show full description
Latest Action: 02/21/2007 - Assigned to Subcommittee Health Care Facilities of HHR Bill TextCompanion Bill SB0842. Hospitals and Health Care Facilities - Requires non-residential methadone clinics to notify clients that treatment options other than methadone are available, removes limit on using treatment options other than methadone. - Amends TCA Title 68, Chapter 11, Part 2. Fiscal Summary for HB0986 / *SB0842Increase State Expenditures - Not Significant Bill Summary for HB0986 / *SB0842 This bill requires the individual treatment plans for clients at non-residential methadone clinics to include any available narcotic replacements other than methadone. There would be no restrictions on the number of clients treated with narcotic replacements other than methadone. This bill also requires health care providers at non-residential methadone clinics to notify their clients of available alternatives to methadone.
Latest Action: 05/02/2007 - Assigned to Gen. Sub of: SenateGW,H&House Resolution Comm. Bill TextCompanion Bill HB0986. Hospitals and Health Care Facilities - Requires non-residential methadone clinics to notify clients that treatment options other than methadone are available, removes limit on using treatment options other than methadone. - Amends TCA Title 68, Chapter 11, Part 2. Fiscal Summary for *SB0842 / HB0986Increase State Expenditures - Not Significant Bill Summary for *SB0842 / HB0986 This bill requires the individual treatment plans for clients at non-residential methadone clinics to include any available narcotic replacements other than methadone. There would be no restrictions on the number of clients treated with narcotic replacements other than methadone. This bill also requires health care providers at non-residential methadone clinics to notify their clients of available alternatives to methadone.
|
Latest Legislation - View All
Latest Action: 03/07/2007 - Assigned to Subcommittee Civil Practice and Procedure of JUD Bill TextCompanion Bill SB2038. Controlled Substances - Adds Soma (Carisoprodol) and Ultram (Tramadol) to Schedule IV controlled substances; requires person to show identification and sign a log at time of purchase of any controlled substance. - Amends TCA Title 39, Chapter 17, Part 4 and Title 63, Chapter 10. Fiscal Summary for *HB1853 / SB2038Increase State Expenditures - Not Significant Increase State Revenues - Not Significant Bill Summary for *HB1853 / SB2038 This bill adds the drugs Soma (Carisoprodol) and Ultram (Tramadol) to the list of Schedule IV controlled substances. This bill also requires pharmacists and pharmacy technicians and interns under the pharmacist's supervision to require any person purchasing any scheduled controlled substance to present a valid government-issued identification at the point of sale and sign a log. A [...] show full description
Latest Action: 06/27/2007 - Public Chapter 498 Bill TextCompanion Bill SB2172. Controlled Substances - Revises provisions governing the disclosure of information obtained under the Controlled Substance Monitoring Act; requires annual report to be filed with certain general assembly committees. - Amends TCA Sections 53-10-306. Fiscal Summary for *HB2234 / SB2172Decrease State Expenditures - Not Significant Bill Summary for *HB2234 / SB2172 Present law requires any health care practitioner who has authority to dispense controlled substances, pharmacists, and pharmacies that dispense to any address within this state to submit information to the controlled substance database advisory committee regarding each dispensation of any Schedule II, III, or IV, and Schedule V controlled substances identified by the committee as demonstrating a potential for abuse. The information required in the reports includes [...] show full description
Latest Action: 06/27/2007 - Companion became Public Chapter 518 Bill TextCompanion Bill SB2192. Controlled Substances - Transfers responsibilities with respect to controlled substance monitoring, including the database and advisory committee, from the department of commerce and insurance to the department of health. - Amends TCA Title 53, Chapter 10, Part 3. Fiscal Summary for *HB2249 / SB2192Increase State Expenditures - Not Significant Bill Summary for *HB2249 / SB2192 ON JUNE 6, 2007, THE SENATE ADOPTED AMENDMENTS #1 AND #2 AND PASSED SENATE BILL 2192, AS AMENDED. AMENDMENT #1 rewrites this bill to transfer the responsibilities with respect to controlled substance monitoring, including the controlled substance database and the controlled substance database advisory committee, from the department and the commissioner of commerce and insurance to the department and commissioner of health. This amendment [...] show full description
Latest Action: 06/06/2007 - Companion became Public Chapter 298 Bill TextCompanion Bill SB2216. Controlled Substances - Adds certain drugs to controlled substances schedule, thereby making it an offense to manufacture, deliver, sell, or possess with the intent to manufacture, deliver, or sell the drug. - Amends TCA Title 39, Chapter 17, Part 4. Fiscal Summary for *HB2267 / SB2216(CORRECTED) Increase State Expenditures - $2,200 / Incarceration* Increase Local Govt. Expenditures - Not Significant Increase Local Govt. Revenues - Not Significant Bill Summary for *HB2267 / SB2216 This bill adds numerous opiates, depressants, stimulants, and narcotics to Schedules I through V of the controlled substances schedule, thereby making it a criminal offense to manufacture, deliver, sell, or possess with the intent to manufacture, deliver, or sell the drugs. This bill moves the depressant glutethimide from Schedule [...] show full description
Latest Action: 04/17/2007 - Assigned to Gen. Sub of: Senate Jud Comm. Bill TextCompanion Bill HB1853. Controlled Substances - Adds Soma (Carisoprodol) and Ultram (Tramadol) to Schedule IV controlled substances; requires person to show identification and sign a log at time of purchase of any controlled substance. - Amends TCA Title 39, Chapter 17, Part 4 and Title 63, Chapter 10. Fiscal Summary for SB2038 / *HB1853Increase State Expenditures - Not Significant Increase State Revenues - Not Significant Bill Summary for SB2038 / *HB1853 This bill adds the drugs Soma (Carisoprodol) and Ultram (Tramadol) to the list of Schedule IV controlled substances. This bill also requires pharmacists and pharmacy technicians and interns under the pharmacist's supervision to require any person purchasing any scheduled controlled substance to present a valid government-issued identification at the point of sale and sign a log. A [...] show full description
Latest Action: 06/27/2007 - Companion became Public Chapter 498 Bill TextCompanion Bill HB2234. Controlled Substances - Revises provisions governing the disclosure of information obtained under the Controlled Substance Monitoring Act; requires annual report to be filed with certain general assembly committees. - Amends TCA Sections 53-10-306. Fiscal Summary for SB2172 / *HB2234Decrease State Expenditures - Not Significant Bill Summary for SB2172 / *HB2234 Present law requires any health care practitioner who has authority to dispense controlled substances, pharmacists, and pharmacies that dispense to any address within this state to submit information to the controlled substance database advisory committee regarding each dispensation of any Schedule II, III, or IV, and Schedule V controlled substances identified by the committee as demonstrating a potential for abuse. The information required in the reports includes [...] show full description
Latest Action: 06/27/2007 - Public Chapter 518 Bill TextCompanion Bill HB2249. Controlled Substances - Transfers responsibilities with respect to controlled substance monitoring, including the database and advisory committee, from the department of commerce and insurance to the department of health. - Amends TCA Title 53, Chapter 10, Part 3. Fiscal Summary for SB2192 / *HB2249Increase State Expenditures - Not Significant Bill Summary for SB2192 / *HB2249 ON JUNE 6, 2007, THE SENATE ADOPTED AMENDMENTS #1 AND #2 AND PASSED SENATE BILL 2192, AS AMENDED. AMENDMENT #1 rewrites this bill to transfer the responsibilities with respect to controlled substance monitoring, including the controlled substance database and the controlled substance database advisory committee, from the department and the commissioner of commerce and insurance to the department and commissioner of health. This amendment [...] show full description
Latest Action: 06/06/2007 - Public Chapter 298 Bill TextCompanion Bill HB2267. Controlled Substances - Adds certain drugs to controlled substances schedule, thereby making it an offense to manufacture, deliver, sell, or possess with the intent to manufacture, deliver, or sell the drug. - Amends TCA Title 39, Chapter 17, Part 4. Fiscal Summary for SB2216 / *HB2267(CORRECTED) Increase State Expenditures - $2,200 / Incarceration* Increase Local Govt. Expenditures - Not Significant Increase Local Govt. Revenues - Not Significant Bill Summary for SB2216 / *HB2267 This bill adds numerous opiates, depressants, stimulants, and narcotics to Schedules I through V of the controlled substances schedule, thereby making it a criminal offense to manufacture, deliver, sell, or possess with the intent to manufacture, deliver, or sell the drugs. This bill moves the depressant glutethimide from Schedule [...] show full description
Latest Action: 02/21/2007 - Assigned to Subcommittee Health Care Facilities of HHR Bill TextCompanion Bill SB0842. Hospitals and Health Care Facilities - Requires non-residential methadone clinics to notify clients that treatment options other than methadone are available, removes limit on using treatment options other than methadone. - Amends TCA Title 68, Chapter 11, Part 2. Fiscal Summary for HB0986 / *SB0842Increase State Expenditures - Not Significant Bill Summary for HB0986 / *SB0842 This bill requires the individual treatment plans for clients at non-residential methadone clinics to include any available narcotic replacements other than methadone. There would be no restrictions on the number of clients treated with narcotic replacements other than methadone. This bill also requires health care providers at non-residential methadone clinics to notify their clients of available alternatives to methadone.
Latest Action: 05/02/2007 - Assigned to Gen. Sub of: SenateGW,H&House Resolution Comm. Bill TextCompanion Bill HB0986. Hospitals and Health Care Facilities - Requires non-residential methadone clinics to notify clients that treatment options other than methadone are available, removes limit on using treatment options other than methadone. - Amends TCA Title 68, Chapter 11, Part 2. Fiscal Summary for *SB0842 / HB0986Increase State Expenditures - Not Significant Bill Summary for *SB0842 / HB0986 This bill requires the individual treatment plans for clients at non-residential methadone clinics to include any available narcotic replacements other than methadone. There would be no restrictions on the number of clients treated with narcotic replacements other than methadone. This bill also requires health care providers at non-residential methadone clinics to notify their clients of available alternatives to methadone.
|
